Span Divergent
BSE: SDL · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Span Divergent's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Span Divergent Limited is a diversified enterprise based in Surat, operating primarily in the food and agriculture sectors alongside healthcare distribution. Following the divestment of its core diagnostics manufacturing business, the company now focuses on value-added agricultural processing and specialized food ingredients.
Business Model
The company generates revenue through the manufacturing and distribution of dehydrated vegetables and food ingredients, complemented by its ongoing activities in the healthcare distribution space.
Growth Outlook
Growth is driven by the expansion of value-added agricultural processing capabilities and the development of innovative health solutions for both domestic and international markets.
Key Risks
- Commodity Price Volatility. Fluctuations in the prices of raw agricultural produce can significantly impact the profit margins of the food processing division.
- Regulatory Compliance. The company faces stringent food safety and healthcare distribution regulations that require continuous investment in quality control and compliance.
- Market Competition. The company operates in highly competitive sectors where it must contend with both established multinational entities and local players.
- Operational Transition Risk. As a restructured entity, the company faces risks associated with successfully scaling its new business lines after exiting its legacy diagnostics manufacturing operations.
Start your research today
Unlock AI insights, financials, peers and live data on Span Divergent and 5,000+ companies — free.
Key Metrics
REVENUE
₹17 Cr
TTM · consolidated
NET PROFIT
₹3 Cr
TTM · consolidated
EPS
₹4.75
TTM · consolidated
RETURN ON EQUITY
45.0%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
-469.8%
TTM · consolidated
P/E
7.8x
Q4 FY26 · consolidated
EV/EBITDA
4.4x
Q4 FY26 · consolidated
EBITDA MARGIN
26.1%
TTM · consolidated
NET PROFIT MARGIN
24.1%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.5x
Q4 FY26 · consolidated
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Span DivergentSDL | ₹23 Cr | 6.62 | 5.23 | 92.0% | 26.1% | 45.0% | -469.8% | +47.7% |
Albert DavidALBERTDAVD | ₹513 Cr | 22.73 | 13.48 | 11.4% | 11.0% | 5.8% | 7.5% | +12.1% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹463 Cr | 13.31 | 8.46 | — | 32.0% | 17.6% | 23.2% | -4.3% |
Haleos Labs LimitedHALEOSLABS | ₹452 Cr | 28.60 | 12.72 | -3.1% | 13.6% | 7.4% | 10.3% | — |
TranschemTRANSCHEM | ₹424 Cr | 98.76 | 68.07 | -100.0% | 177.7% | 5.3% | 7.0% | +592.6% |
Medicamen BiotecMEDICAMEQ | ₹338 Cr | 33.59 | 15.53 | 24.7% | 11.3% | 4.1% | 6.2% | -27.9% |
As of Q4 FY26
Financials
Span Divergent
BSE: SDL · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Span Divergent's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Span Divergent Limited is a diversified enterprise based in Surat, operating primarily in the food and agriculture sectors alongside healthcare distribution. Following the divestment of its core diagnostics manufacturing business, the company now focuses on value-added agricultural processing and specialized food ingredients.
Business Model
The company generates revenue through the manufacturing and distribution of dehydrated vegetables and food ingredients, complemented by its ongoing activities in the healthcare distribution space.
Growth Outlook
Growth is driven by the expansion of value-added agricultural processing capabilities and the development of innovative health solutions for both domestic and international markets.
Key Risks
- Commodity Price Volatility. Fluctuations in the prices of raw agricultural produce can significantly impact the profit margins of the food processing division.
- Regulatory Compliance. The company faces stringent food safety and healthcare distribution regulations that require continuous investment in quality control and compliance.
- Market Competition. The company operates in highly competitive sectors where it must contend with both established multinational entities and local players.
- Operational Transition Risk. As a restructured entity, the company faces risks associated with successfully scaling its new business lines after exiting its legacy diagnostics manufacturing operations.
Start your research today
Unlock AI insights, financials, peers and live data on Span Divergent and 5,000+ companies — free.
Key Metrics
REVENUE
₹17 Cr
TTM · consolidated
NET PROFIT
₹3 Cr
TTM · consolidated
EPS
₹4.75
TTM · consolidated
RETURN ON EQUITY
45.0%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
-469.8%
TTM · consolidated
P/E
7.8x
Q4 FY26 · consolidated
EV/EBITDA
4.4x
Q4 FY26 · consolidated
EBITDA MARGIN
26.1%
TTM · consolidated
NET PROFIT MARGIN
24.1%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.5x
Q4 FY26 · consolidated
Peers · Pharmaceuticals
As of Q4 FY26